Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments
- PMID: 11124952
- DOI: 10.1074/jbc.M009172200
Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments
Abstract
Deletion of phenylalanine at position 508 (DeltaF508) is the most common cystic fibrosis (CF)-associated mutation in the CF transmembrane conductance regulator (CFTR), a cAMP-regulated chloride channel. The consensus notion is that DeltaF508 imposes a temperature-sensitive folding defect and targets newly synthesized CFTR for degradation at endoplasmic reticulum (ER). A limited amount of CFTR activity, however, appears at the cell surface in the epithelia of homozygous DeltaF508 CFTR mice and patients, suggesting that the ER retention is not absolute in native tissues. To further elucidate the reasons behind the inability of DeltaF508 CFTR to accumulate at the plasma membrane, its stability was determined subsequent to escape from the ER, induced by reduced temperature and glycerol. Biochemical and functional measurements show that rescued DeltaF508 CFTR has a temperature-sensitive stability defect in post-ER compartments, including the cell surface. The more than 4-20-fold accelerated degradation rate between 37 and 40 degrees C is, most likely, due to decreased conformational stability of the rescued DeltaF508 CFTR, demonstrated by in situ protease susceptibility and SDS-resistant thermoaggregation assays. We propose that the decreased stability of the spontaneously or pharmacologically rescued mutant may contribute to its inability to accumulate at the cell surface. Thus, therapeutic efforts to correct the folding defect should be combined with stabilization of the native DeltaF508 CFTR.
Similar articles
-
Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.Curr Mol Med. 2010 Feb;10(1):82-94. doi: 10.2174/156652410791065408. Curr Mol Med. 2010. PMID: 20205681 Free PMC article. Review.
-
Diffusional mobility of the cystic fibrosis transmembrane conductance regulator mutant, delta F508-CFTR, in the endoplasmic reticulum measured by photobleaching of GFP-CFTR chimeras.J Biol Chem. 2002 May 10;277(19):16419-25. doi: 10.1074/jbc.M112361200. Epub 2002 Feb 27. J Biol Chem. 2002. PMID: 11877404
-
Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.Gastroenterology. 2005 Dec;129(6):1979-90. doi: 10.1053/j.gastro.2005.08.049. Gastroenterology. 2005. PMID: 16344066
-
Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and DeltaF508 CFTR.Biochim Biophys Acta. 2008 Sep;1783(9):1585-94. doi: 10.1016/j.bbamcr.2008.04.002. Epub 2008 Apr 16. Biochim Biophys Acta. 2008. PMID: 18457676
-
Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting.Adv Drug Deliv Rev. 2002 Dec 5;54(11):1395-408. doi: 10.1016/s0169-409x(02)00148-5. Adv Drug Deliv Rev. 2002. PMID: 12458151 Review.
Cited by
-
Fixing cystic fibrosis by correcting CFTR domain assembly.J Cell Biol. 2012 Oct 15;199(2):199-204. doi: 10.1083/jcb.201208083. J Cell Biol. 2012. PMID: 23071149 Free PMC article.
-
Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells.Mol Biol Cell. 2010 Jan 1;21(1):73-86. doi: 10.1091/mbc.e09-03-0185. Epub 2009 Nov 4. Mol Biol Cell. 2010. PMID: 19889841 Free PMC article.
-
Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.Curr Mol Med. 2010 Feb;10(1):82-94. doi: 10.2174/156652410791065408. Curr Mol Med. 2010. PMID: 20205681 Free PMC article. Review.
-
Activation of endoplasmic reticulum stress response during the development of ischemic heart disease.Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1411-20. doi: 10.1152/ajpheart.01378.2005. Epub 2006 Apr 14. Am J Physiol Heart Circ Physiol. 2006. PMID: 16617122 Free PMC article.
-
Biosynthesis of mucin type O-glycans: lack of correlation between glycosyltransferase and sulfotransferase activities and CFTR expression.Glycoconj J. 2001 Sep;18(9):685-97. doi: 10.1023/a:1020819305931. Glycoconj J. 2001. PMID: 12386454
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources